CDMO Avid Bioservices Inc

Avid Bioservices Inc is engaged in development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture.

$25.91  -0.03 (-0.12%)
As of 07/26/2021 09:33:20 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  61,097,671
Average volume:  676,412
Market cap:   $1,564,100,378
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    05368M106
ISIN:        US05368M1062
Sedol:      BFMZ4W7

---

Valuation   (See tab for details)

---

PE ratio:   477.66
PB ratio:   20.38
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%